Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I–II GIMEMA trial.

Autor: Mauro, Francesca R.1 (AUTHOR) mauro@bce.uniroma1.it, Carella, Angelo M.2 (AUTHOR), Molica, Stefano3 (AUTHOR), Paoloni, Francesca4 (AUTHOR), Liberati, Anna M.5 (AUTHOR), Zaja, Francesco6 (AUTHOR), Belsito, Valeria7 (AUTHOR), Cortellezzi, Agostino8 (AUTHOR), Rizzi, Rita9 (AUTHOR), Tosi, Patrizia10 (AUTHOR), Spriano, Mauro2 (AUTHOR), Ferretti, Antonietta1 (AUTHOR), Nanni, Mauro1 (AUTHOR), Marinelli, Marilisa1 (AUTHOR), De Propris, Maria S.1 (AUTHOR), Orlando, Sonia M.4 (AUTHOR), Vignetti, Marco4 (AUTHOR), Cuneo, Antonio11 (AUTHOR), Guarini, Anna R.1,12 (AUTHOR), Foà, Robin1 (AUTHOR)
Zdroj: Leukemia & Lymphoma. July2017, Vol. 58 Issue 7, p1640-1647. 8p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje